FACTANKER · measured, cited, anchored official records connected

Alterola Biotech, Inc. — Net Income by Fiscal Year

15 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/11f37369-37c7-4b52-afb3-50693526b2f9/serie/net-income

Fiscal yearNet IncomePeriodEvidence
FY 2023$-2.4M2023-04-01 – 2024-03-31evidence 0001663577-24-000211
FY 2022$-2.1M2022-04-01 – 2023-03-31evidence 0001663577-24-000211
FY 2021$-6.5M2021-04-01 – 2022-03-31evidence 0001663577-22-000372
FY 2020$-309.5k2020-04-01 – 2021-03-31evidence 0001663577-22-000372
FY 2019$-258.7k2018-10-01 – 2019-09-30evidence 0001663577-21-000147
FY 2018$-113.1k2017-10-01 – 2018-09-30evidence 0001663577-21-000093
FY 2017$-67.6k2016-10-01 – 2017-09-30evidence 0001663577-20-000363
FY 2016$-22.6k2015-10-01 – 2016-09-30evidence 0001663577-20-000468
FY 2015$-36.1k2014-10-01 – 2015-09-30evidence 0001662252-15-000008
FY 2014$-54.9k2013-10-01 – 2014-09-30evidence 0001255294-15-000022
FY 2013$-72.5k2012-10-01 – 2013-09-30evidence 0001255294-14-000405
FY 2012$-13.2k2011-10-01 – 2012-09-30evidence 0001255294-14-000155
FY 2011$-106.1k2010-10-01 – 2011-09-30evidence 0001255294-14-000122
FY 2010$-128.9k2009-10-01 – 2010-09-30evidence 0001255294-14-000122
FY 2009$-97.2k2008-10-01 – 2009-09-30evidence 0001255294-14-000122
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

Alterola Biotech, Inc. — all facts · Revenue · Operating Income